Sherlock Biosciences, Inc.
Sherlock Biosciences is dedicated to providing global access to the simplest and most accurate tests that empower individuals to control their own healthcare. Through its Engineering Biology platforms, the company is developing applications of SHERLOCK, a CRISPR-based method for “smart amplicon detection,” and INSPECTR, a synthetic biology-based molecular diagnostics platform that is instrument-free. SHERLOCK and INSPECTR can be used in virtually any setting without complex instrumentation, opening up a wide range of potential applications in areas including precision oncology, infection identification, food safety, at-home tests and disease detection in the field. In 2020, the company made history with the first FDA-authorized use of CRISPR technology.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
About Us
Sherlock Biosciences is disrupting diagnostics.
- Sherlock Biosciences was founded on the belief that we can vastly improve human health and industrial testing worldwide.
- Diagnostic tests developed with our Engineering Biology platforms will help us deliver results faster, accurately and more affordably.
Sherlock Biosciences aims to disrupt diagnostics by providing accurate, actionable health information wherever and whenever it is needed.
With our unique Engineering Biology platforms, we are on the cusp of solving challenges ranging from faster pathogen detection and simpler testing for cancer to improved food safety. We envision a world where our products will enable users to make more effective decisions in any environment, whether in hospitals, industrial settings, the developing world, or at home. We provide trusted results on your terms.
Providing access to the simplest and most accurate tests that empower individuals to control their own healthcare.
The new standard for molecular diagnostics.
Our Vision
We envision a world where Sherlock’s products will enable users to make more effective decisions in any environment, including hospitals, industrial settings, low-resource settings, or at home.
Our goal is to address significant unmet needs in infectious disease, oncology, agriculture, and other areas to transform diagnostic testing and global public health.
Our Commitment
We are committed to making a positive impact on human health, including in low-resource settings, where rapid diagnostic testing has the potential to transform lives through better health care and safer food and water.
Partnering
Broad partnerships accelerate the pace of improved health
By partnering broadly, we will accelerate the pace of improved human health through SHERLOCK™- and INSPECTR™-based product development, increase the reach of these testing solutions, and expand our platforms’ capabilities. Sherlock’s diagnostic tests can be used in many applications and settings. We intend to leverage this versatility, and work with partners to develop, validate and commercialize tests for clinical and non-clinical settings and with diverse applications.
Pioneers in Engineering Biology
Veterans of the diagnostic industry. Disease experts.
Sherlock’s team has deep experience in the diagnostic industry and with the most important innovations that are revolutionizing the field. Our team and founders include Engineering Biology pioneers with world-leading expertise in CRISPR and Synthetic Biology, diagnostic industry veterans, and disease-area authorities. Together, they provide an unparalleled set of capabilities that are transforming molecular diagnostics in clinical and non-clinical settings.
Simple and Easy to Use.
A truly unique approach to disease detection.
Sherlock Biosciences is developing the most advanced platforms in molecular testing to offer unparalleled breadth and versatility for diagnostic solutions. Our company is named after one of our foundational platform technologies, Specific High sensitivity Enzymatic Reporter unLOCKing, or SHERLOCKTM. SHERLOCK is a method for identifying specific sequences of genetic material in a sample using CRISPR.
We combine the diagnostic power of SHERLOCK with that of a second core platform technology, Internal Splint-Pairing Expression Cassette Translation Reaction, or INSPECTRTM, to create diagnostic tools that are simple and easy to use in virtually any setting, and at the same time provide accurate, rapid and affordable results.
Together we will improve health outcomes worldwide.
We recognized early on that teaming with disease-area and diagnostic experts could accelerate the rate at which we make a difference for people worldwide. That’s why we are partnering with leading organizations to develop and commercialize tests using our Engineering Biology technologies. With a team of experienced scientists and industry veterans, we are poised to work alongside partners to rapidly develop better tests and put them in the hands of more people.